New BARDA Award: MBio Diagnostics, Inc. null
Post# of 36533
(Total Views: 380)
Posted On: 06/23/2020 11:32:40 AM
New BARDA Award:
MBio Diagnostics, Inc. null
Product Name: MBio COVID-19 Antibody Panel
View Announcement
Description:
The MBio COVID-19 Antibody Panel is a high performance point-of-care for seroprevalence studies, to assess exposure and potential immunity to SARS-CoV-2 virus. It may be used an orthogonal method to confirm positive results reported by another method.
Unique Impact:
MBio’s COVID-19 Antibody Panel quantitatively measures IgM and IgG antibodies and antigen simultaneously. IgM indicates recent infection and IgG likely provide some level of protection from re-infection. This 5-minute test potentially could be used to measure IgG levels in recovered patients for plasma donation in a convenient point-of-care format.
Award Amount: $629,595.00
Cost Share: Yes
MBio Diagnostics, Inc. null
Product Name: MBio COVID-19 Antibody Panel
View Announcement
Description:
The MBio COVID-19 Antibody Panel is a high performance point-of-care for seroprevalence studies, to assess exposure and potential immunity to SARS-CoV-2 virus. It may be used an orthogonal method to confirm positive results reported by another method.
Unique Impact:
MBio’s COVID-19 Antibody Panel quantitatively measures IgM and IgG antibodies and antigen simultaneously. IgM indicates recent infection and IgG likely provide some level of protection from re-infection. This 5-minute test potentially could be used to measure IgG levels in recovered patients for plasma donation in a convenient point-of-care format.
Award Amount: $629,595.00
Cost Share: Yes
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼